Ducentis BioTherapeutics

Greater London Legal Chronicle. September 13, 2022

Arcutis Biotherapeutics’ $400 Million Acquisition of Ducentis BioTherapeutics

By Martina Bellini

In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Ducentis BioTherapeutics with a team including Graham Defries (Picture – Life Science & Health Care),...

This content is for members only.
Join Now

Already a member? Log in here

Sixth Street and Copley Point Capital’s Joint Venture for UK Industrial Real Estate

Tata SIA Airlines’ Merger With Air India

Zorlu Enerji’s US$200 Million Sustainability-Linked Eurobond Issuance

Pivotal’s Acquisition of Security Plus Limited

Schenk Tanktransport’s Acquisition Of Suttons Tankers

Alicorn Venture Partners’ Acquisition Of Glassbox

Coigach Community Development Company’s Acquisition Of 7,900 Acres Of Tenanted Croft Land And Common Grazings

Robert P. Slight & Sons’ Sale to EOT

Connelly Group Holdings’ Acquisition of Scottish Security & Fire Systems

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Phoenix Equity Partners’ £200 Million Launch of Growth Partnership Fund

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

McDermott Strengthens Global Private Equity Offering With New Hire in London

Curtis Boosts London Finance and Corporate Capability with Appointment of Partner Christopher Harrison

Arcutis Biotherapeutics’ $400 Million Acquisition of Ducentis BioTherapeutics